Know Cancer

or
forgot password
  • cancer clinical trials in chicago, IL

  • Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
    The University of Chicago
    Chicago, Illinois 60637
    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma
    Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Rush University Medical Center
    Northwestern University Feinberg School of Medicine
    Acute Myeloid Leukemia
    Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer
    Rush University Medical Center
    Chicago, Illinois 60612-3824
    Pancreatic Cancer
    Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia
    University of Chicago - Department of Surgery
    Chicago, Illinois 60637
    Prostatic Hyperplasia
    A Study of XL184 (Cabozantinib) With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
    University of Chicago Medical Center
    Chicago, Illinois 60637
    Carcinoma, Non-Small-Cell Lung
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Illinois Masonic Medical Center

    Trial Locations
    Illinois Masonic Medical Center
    Mercy Hospital and Medical Center
    Mount Sinai Hospital Medical Center
    University of Chicago Comprehensive Cancer Center
    John H Stroger Jr Hospital of Cook County
    Resurrection Healthcare
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Swedish Covenant Hospital

    Trial Locations
    Swedish Covenant Hospital
    Mount Sinai Hospital Medical Center
    University of Chicago Comprehensive Cancer Center
    University of Illinois
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer
    University of Chicago
    Chicago, Illinois 60637
    Esophageal Cancer
    HLA-Identical Sibling Renal Transplant Tolerance With Donor Hematopoietic Stem Cells and Campath-1H
    Northwestern Memorial Hospital
    Chicago, Illinois 60611
    Immunosuppression, Kidney Transplantation, Graft Rejection
    Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
    Children's Memorial Hospital
    Chicago, Illinois 60614
    Leukemia, Myelogenous, Chronic, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute, Myeloproliferative-Myelodysplastic Diseases, Lymphoma, Malignant
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    MBCCOP, John H. Stroger, JR., Hospital of Cook County-Chicago
    Breast Cancer
    Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients
    Northwestern University
    Chicago, Illinois 60611
    Dysphagia
    Development and Validation of a Symptom Scale for Children With Chronic Graft-Versus-Host Disease
    Childrens Memorial Hospital
    Chicago, Illinois 60614
    Graft vs Host Disease
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Swedish Covenant Hospital
    Creticos Cancer Center at Advocate Illinois Masonic Medical Center
    John H. Stroger, Jr. Hospital of Cook County
    Resurrection Medical Center
    Lung Cancer
    A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
    Ann & Robert H. Lurie Children's Hospital of Chicago (Formerly Children's Memorial Hospital)
    Chicago, Illinois 60611
    Malignant Glioma, Recurrent Ependymoma
    Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Northwestern University
    Chicago, Illinois 60611
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Myeloid Leukemia
    A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
    University of Chicago
    Chicago, Illinois 60637
    Neurofibromatosis Type 1
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Hematology and Oncology Associates

    Trial Locations
    Hematology and Oncology Associates
    Northwestern University
    University of Illinois
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    University of Illinois Cancer Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Leukemia
    Phase II R-ABVD Versus ABVD for Advanced Stage Classical Hodgkin Lymphoma
    Rush University
    Chicago, Illinois 60612
    Hodgkin Lymphoma
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Esophageal Cancer
    Research Tissue Bank
    University of Illinois at Chicago
    Chicago, Illinois 60612
    Myelofibrosis, Idiopathic Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera
    CEP-701 (Lestaurtinib) in Myelofibrosis
    University of Illinois at Chicago
    Chicago, Illinois 60612
    Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera
    Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
    Northwestern University Medical Center

    Trial Locations
    Northwestern University Medical Center
    University of Chicago Hospitals and Clinics
    Prostate Cancer
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    Children's Memorial Hospital - Chicago

    Trial Locations
    Children's Memorial Hospital - Chicago
    University of Illinois Cancer Center
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
    The University of Chicago
    Chicago, Illinois 60637
    Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia, Malignant Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia, Myeloproliferative Disorder, Anemia, Aplastic, Myelodysplastic Syndromes
    A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
    University of Chicago
    Chicago, Illinois 60637
    Malignant Glioma, Glioblastoma Multiforme, GBM, Astrocytoma, Oligodendroglioma
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Illinois Masonic Medical Center
    Chicago, Illinois 60657
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
    Rush University Medical Center
    Chicago, Illinois 60612-3824
    Mesothelioma